Sialylation	O
of	O
the	O
prion	B-GP
protein	O
glycans	O
controls	O
prion	B-GP
replication	O
rate	O
and	O
glycoform	O
ratio	O

Prion	B-GP
or	O
PrPSc	O
is	O
a	O
proteinaceous	O
infectious	O
agent	O
that	O
consists	O
of	O
a	O
misfolded	O
and	O
aggregated	O
form	O
of	O
a	O
sialoglycoprotein	B-GP
called	O
prion	B-GP
protein	O
or	O
PrPC	O
.	O

PrPC	O
has	O
two	O
sialylated	O
N	O
-	O
linked	O
carbohydrates	O
.	O

In	O
PrPSc	O
,	O
the	O
glycans	O
are	O
directed	O
outward	O
,	O
with	O
the	O
terminal	O
sialic	O
acid	O
residues	O
creating	O
a	O
negative	O
charge	O
on	O
the	O
surface	O
of	O
prion	B-GP
particles	O
.	O

The	O
current	O
study	O
proposes	O
a	O
new	O
hypothesis	O
that	O
electrostatic	O
repulsion	O
between	O
sialic	O
residues	O
creates	O
structural	O
constraints	O
that	O
control	O
prion	B-GP
replication	O
and	O
PrPSc	O
glycoform	O
ratio	O
.	O

In	O
support	O
of	O
this	O
hypothesis	O
,	O
here	O
we	O
show	O
that	O
diglycosylated	O
PrPC	O
molecules	O
that	O
have	O
more	O
sialic	O
groups	O
per	O
molecule	O
than	O
monoglycosylated	O
PrPC	O
were	O
preferentially	O
excluded	O
from	O
conversion	O
.	O

However	O
,	O
when	O
partially	O
desialylated	O
PrPC	O
was	O
used	O
as	O
a	O
substrate	O
,	O
recruitment	O
of	O
three	O
glycoforms	O
into	O
PrPSc	O
was	O
found	O
to	O
be	O
proportional	O
to	O
their	O
respective	O
populations	O
in	O
the	O
substrate	O
.	O

In	O
addition	O
,	O
hypersialylated	O
molecules	O
were	O
also	O
excluded	O
from	O
conversion	O
in	O
the	O
strains	O
with	O
the	O
strongest	O
structural	O
constraints	O
,	O
a	O
strategy	O
that	O
helped	O
reduce	O
electrostatic	O
repulsion	O
.	O

Moreover	O
,	O
as	O
predicted	O
by	O
the	O
hypothesis	O
,	O
partial	O
desialylation	O
of	O
PrPC	O
significantly	O
increased	O
the	O
replication	O
rate	O
.	O

This	O
study	O
illustrates	O
that	O
sialylation	O
of	O
N	O
-	O
linked	O
glycans	O
creates	O
a	O
prion	B-GP
replication	O
barrier	O
that	O
controls	O
replication	O
rate	O
and	O
glycoform	O
ratios	O
and	O
has	O
broad	O
implications	O
.	O

Prion	B-DS
diseases	I-DS
are	O
a	O
family	O
of	O
lethal	O
,	O
transmissible	O
,	O
neurodegenerative	B-DS
disorders	I-DS
that	O
can	O
be	O
sporadic	O
,	O
inheritable	O
or	O
transmissible	O
in	O
origin12	O
.	O

A	O
central	O
event	O
underlying	O
the	O
molecular	O
mechanism	O
of	O
prion	B-DS
diseases	I-DS
involves	O
conformational	O
changes	O
of	O
the	O
cellular	O
form	O
of	O
the	O
prion	B-GP
protein	O
(	O
PrPC	O
)	O
into	O
the	O
disease	O
-	O
associated	O
transmissible	O
form	O
(	O
PrPSc	O
)	O
1	O
.	O

Multiple	O
alternative	O
,	O
conformationally	O
distinct	O
,	O
self	O
-	O
replicating	O
states	O
referred	O
to	O
as	O
prion	B-GP
strains	O
that	O
give	O
rise	O
to	O
different	O
prion	B-DS
disease	I-DS
phenotypes	O
can	O
be	O
produced	O
within	O
the	O
same	O
host	O
or	O
PrPC	O
amino	O
acid	O
sequence3456	O
.	O

Among	O
the	O
parameters	O
identified	O
over	O
the	O
years	O
that	O
control	O
prion	B-GP
transmission	O
and	O
replication	O
are	O
the	O
amino	O
acid	O
sequence	O
of	O
PrPC	O
and	O
strain	O
-	O
specific	O
structure	O
of	O
PrPSc7	O
.	O

PrPC	O
is	O
subject	O
to	O
two	O
types	O
of	O
posttranslational	O
modifications	O
,	O
which	O
include	O
attachment	O
of	O
GPI	O
anchor	O
to	O
the	O
C	O
-	O
terminal	O
residue	O
Ser	O
-	O
231	O
and	O
up	O
to	O
two	O
N	O
-	O
linked	O
carbohydrates	O
to	O
residues	O
Asn	O
-	O
181	O
and	O
Asn	O
-	O
197891011	O
.	O

Roles	O
of	O
N	O
-	O
linked	O
glycans	O
and	O
the	O
GPI	O
-	O
anchor	O
in	O
prion	B-GP
transmission	O
,	O
spread	O
,	O
and	O
pathogenesis	O
have	O
been	O
the	O
subjects	O
of	O
a	O
number	O
of	O
studies	O
in	O
the	O
last	O
decade1213141516	O
.	O

The	O
N	O
-	O
linked	O
glycans	O
are	O
sialylated	O
at	O
the	O
terminal	O
positions	O
,	O
with	O
each	O
glycan	O
being	O
able	O
to	O
carry	O
up	O
to	O
five	O
sialic	O
acid	O
residues17	O
.	O

Despite	O
the	O
discovery	O
of	O
PrP	B-GP
sialylation	O
more	O
than	O
25	O
years	O
ago	O
,	O
the	O
potential	O
role	O
of	O
sialylation	O
in	O
prion	B-GP
replication	O
has	O
not	O
been	O
explored	O
.	O

Terminal	O
sialylation	O
of	O
glycans	O
significantly	O
alters	O
the	O
physical	O
properties	O
of	O
both	O
states	O
,	O
PrPC	O
and	O
PrPSc	O
.	O

In	O
the	O
absence	O
of	O
posttranslational	O
modifications	O
,	O
the	O
theoretical	O
pI	O
of	O
the	O
full	O
-	O
length	O
prion	B-GP
protein	O
is	O
9	O
.	O
6	O
and	O
the	O
estimated	O
charge	O
at	O
pH	O
7	O
.	O
5	O
is	O
+	O
9	O
.	O
518	O
.	O

However	O
,	O
due	O
to	O
glycan	O
sialylation	O
,	O
the	O
actual	O
pI	O
of	O
PrP	B-GP
molecules	O
was	O
found	O
to	O
be	O
highly	O
heterogeneous	O
and	O
spread	O
from	O
pH	O
9	O
.	O
6	O
to	O
acidic	O
pH1819	O
.	O

In	O
intact	O
PrPSc	O
,	O
the	O
glycans	O
are	O
believed	O
to	O
be	O
directed	O
outwards	O
,	O
with	O
the	O
terminal	O
sialic	O
acid	O
residues	O
located	O
at	O
the	O
interface	O
with	O
the	O
extracellular	O
environment	O
or	O
solvent202122	O
.	O

Because	O
sialic	O
acid	O
residues	O
create	O
a	O
dense	O
negative	O
charge	O
on	O
the	O
PrPSc	O
surface	O
,	O
glycan	O
sialylation	O
might	O
play	O
a	O
major	O
role	O
in	O
modulating	O
interactions	O
between	O
PrPSc	O
and	O
PrPC	O
and	O
defining	O
prion	B-GP
replication	O
rate	O
.	O

In	O
previous	O
study	O
,	O
we	O
showed	O
that	O
sialylation	O
level	O
of	O
PrPSc	O
controls	O
prion	B-GP
infectivity18	O
.	O

We	O
also	O
noticed	O
that	O
changes	O
in	O
sialylation	O
levels	O
of	O
PrPC	O
influence	O
PrPSc	O
replication	O
rate	O
and	O
the	O
ratio	O
of	O
three	O
glycoforms	O
within	O
newly	O
formed	O
PrPSc	O
.	O

These	O
findings	O
led	O
to	O
a	O
new	O
hypothesis	O
that	O
electrostatic	O
repulsion	O
between	O
sialic	O
acid	O
residues	O
creates	O
a	O
replication	O
barrier	O
that	O
slows	O
down	O
prion	B-GP
replication	O
.	O

Moreover	O
,	O
as	O
diglycosylated	O
glycoforms	O
have	O
more	O
sialic	O
acid	O
residues	O
per	O
PrP	B-GP
molecule	O
than	O
mono	O
-	O
or	O
unglycosylated	O
glycoforms	O
,	O
this	O
hypothesis	O
also	O
proposes	O
that	O
sialylation	O
controls	O
PrPSc	O
glycoform	O
ratios	O
.	O

In	O
previous	O
studies	O
that	O
examined	O
prions	O
formed	O
in	O
familial	O
and	O
sporadic	O
prion	B-DS
diseases	I-DS
,	O
the	O
three	O
glycoforms	O
were	O
found	O
to	O
be	O
recruited	O
into	O
PrPSc	O
in	O
a	O
selective	O
fashion23	O
.	O

PrPSc	O
glycoform	O
ratios	O
are	O
believed	O
to	O
be	O
an	O
intrinsic	O
characteristic	O
of	O
prion	B-GP
strains	O
or	O
subtypes	O
and	O
,	O
as	O
such	O
,	O
have	O
been	O
used	O
for	O
strain	O
typing2425	O
.	O

However	O
,	O
it	O
still	O
remains	O
puzzling	O
as	O
to	O
why	O
the	O
proportions	O
of	O
three	O
glycoforms	O
vary	O
in	O
a	O
strain	O
-	O
specific	O
manner	O
,	O
even	O
within	O
the	O
same	O
host	O
.	O

Here	O
we	O
propose	O
that	O
diglycosylated	O
glycoforms	O
are	O
selectively	O
excluded	O
to	O
reduce	O
electrostatic	O
repulsion	O
between	O
sialic	O
acid	O
residues	O
within	O
PrPSc	O
.	O

The	O
current	O
study	O
tests	O
the	O
above	O
hypothesis	O
on	O
the	O
role	O
of	O
sialylation	O
in	O
controlling	O
the	O
prion	B-GP
replication	O
barrier	O
and	O
glycoform	O
ratios	O
.	O

Results	O

Sialylation	O
status	O
controls	O
strain	O
-	O
specific	O
glycoform	O
ratio	O
of	O
PrPSc	O

For	O
establishing	O
a	O
relationship	O
between	O
sialylation	O
status	O
and	O
glycoform	O
ratios	O
,	O
a	O
panel	O
of	O
hamster	B-OG
(	O
263K	O
,	O
HY	O
,	O
DY	O
and	O
SSLOW	O
)	O
and	O
mouse	B-OG
(	O
ME7	O
,	O
22L	O
and	O
RML	O
)	O
strains	O
were	O
employed	O
.	O

To	O
produce	O
PrPSc	O
with	O
reduced	O
sialylation	O
levels	O
,	O
normal	O
brain	O
homogenate	O
(	O
NBH	O
)	O
was	O
treated	O
with	O
sialidase	B-GP
from	O
Arthrobacter	B-OG
ureafaciens	I-OG
,	O
which	O
has	O
broad	O
substrate	O
specificity	O
and	O
cleaves	O
α2	O
–	O
3	O
and	O
α2	O
–	O
6	O
linked	O
sialic	O
acid	O
residues	O
on	O
N	O
-	O
linked	O
glycans	O
.	O

Sialidase	B-GP
treated	O
NBH	O
was	O
used	O
as	O
a	O
substrate	O
for	O
PMCAb	O
(	O
a	O
PMCAb	O
format	O
that	O
utilizes	O
desialylated	O
substrate	O
will	O
be	O
referred	O
to	O
as	O
dsPMCAb	O
)	O
as	O
previously	O
described18	O
.	O

Western	O
blots	O
were	O
used	O
to	O
compare	O
the	O
glycoform	O
ratios	O
in	O
PrPSc	O
and	O
dsPMCAb	O
products	O
(	O
Fig	O
.	O
1	O
).	O

All	O
mouse	B-OG
and	O
hamster	B-OG
strains	O
tested	O
showed	O
significant	O
increase	O
in	O
diglycosylated	O
glycoforms	O
at	O
the	O
expense	O
of	O
mono	O
-	O
and	O
unglycosylated	O
glycoforms	O
in	O
dsPMCAb	O
products	O
in	O
comparison	O
to	O
corresponding	O
brain	O
-	O
derived	O
materials	O
(	O
Fig	O
.	O
1A	O
,	O
B	O
).	O

All	O
three	O
mouse	B-OG
strains	O
(	O
ME7	O
,	O
22L	O
,	O
RML	O
)	O
showed	O
considerable	O
amounts	O
of	O
mono	O
-	O
and	O
unglycosylated	O
glycoforms	O
in	O
dsPMCAb	O
products	O
relative	O
to	O
that	O
of	O
dsPMCAb	O
-	O
derived	O
material	O
of	O
hamster	B-OG
strains	O
(	O
263K	O
,	O
HY	O
,	O
DY	O
,	O
SSLOW	O
).	O

This	O
higher	O
proportion	O
of	O
mono	O
-	O
and	O
non	O
-	O
glycosylated	O
forms	O
is	O
a	O
distinct	O
trait	O
of	O
mouse	B-OG
strains	O
,	O
as	O
all	O
brain	O
-	O
derived	O
mouse	B-OG
materials	O
also	O
showed	O
higher	O
proportions	O
of	O
mono	O
-	O
and	O
unglycosylated	O
forms	O
relative	O
to	O
those	O
of	O
hamster	B-OG
strains26	O
.	O

Nevertheless	O
,	O
a	O
considerable	O
shift	O
in	O
glycoform	O
ratios	O
in	O
favor	O
of	O
diglycosylated	O
forms	O
was	O
observed	O
in	O
all	O
mouse	B-OG
and	O
hamster	B-OG
strains	O
.	O

The	O
differences	O
in	O
sialylation	O
status	O
between	O
brain	O
-	O
and	O
dsPMCAb	O
-	O
derived	O
materials	O
were	O
analyzed	O
using	O
2D	O
gel	O
electrophoresis	O
.	O

The	O
two	O
N	O
-	O
linked	O
glycans	O
can	O
carry	O
up	O
to	O
five	O
terminal	O
sialic	O
acid	O
residues	O
each	O
adding	O
negative	O
charges	O
to	O
individual	O
PrP	B-GP
molecules17	O
.	O

Because	O
the	O
samples	O
were	O
denatured	O
prior	O
to	O
2D	O
gel	O
electrophoresis	O
,	O
the	O
distribution	O
of	O
charge	O
isoforms	O
in	O
the	O
horizontal	O
dimension	O
reflects	O
sialylation	O
status	O
of	O
individual	O
PrP	B-GP
molecules	O
,	O
where	O
hypersialylated	O
molecules	O
run	O
toward	O
acidic	O
pH	O
and	O
hyposialylated	O
toward	O
basic	O
pH18	O
.	O

Consistent	O
with	O
previous	O
studies2728	O
,	O
unglycosylated	O
forms	O
that	O
lack	O
glycans	O
and	O
glycan	O
-	O
linked	O
sialylation	O
typically	O
showed	O
more	O
than	O
one	O
charge	O
isoforms	O
(	O
Fig	O
.	O
2	O
).	O

This	O
charge	O
heterogeneity	O
is	O
attributed	O
to	O
the	O
structural	O
heterogeneity	O
of	O
the	O
GPI	O
anchors	O
,	O
a	O
fraction	O
of	O
which	O
could	O
be	O
also	O
subject	O
to	O
single	O
sialylation8	O
.	O

Unglycosylated	O
forms	O
could	O
serve	O
as	O
a	O
reference	O
for	O
charge	O
heterogeneity	O
resolved	O
by	O
2D	O
not	O
attributable	O
to	O
sialylation	O
of	O
N	O
-	O
linked	O
glycans	O
.	O

For	O
all	O
strains	O
tested	O
,	O
the	O
distribution	O
of	O
dsPMCAb	O
-	O
derived	O
products	O
was	O
shifted	O
towards	O
basic	O
pH	O
relative	O
to	O
that	O
of	O
brain	O
-	O
derived	O
materials	O
as	O
expected	O
(	O
Fig	O
.	O
2	O
).	O

Such	O
shifts	O
document	O
changes	O
in	O
sialylation	O
status	O
of	O
dsPMCAb	O
-	O
derived	O
materials	O
that	O
were	O
produced	O
from	O
a	O
partially	O
desialylated	O
substrate	O
.	O

To	O
analyze	O
individual	O
sialylation	O
profiles	O
,	O
charged	O
isoforms	O
were	O
separated	O
arbitrarily	O
into	O
two	O
categories	O
,	O
as	O
described	O
in	O
Methods	O
.	O

Isoforms	O
located	O
toward	O
acidic	O
pH	O
from	O
pI	O
7	O
.	O
5	O
will	O
be	O
designated	O
as	O
hypersialylated	O
and	O
those	O
toward	O
basic	O
pH	O
will	O
be	O
designated	O
as	O
hyposialylated	O
.	O

The	O
percentage	O
of	O
sum	O
intensities	O
of	O
hypersialylated	O
isoforms	O
relative	O
to	O
the	O
total	O
intensities	O
of	O
all	O
isoforms	O
was	O
used	O
to	O
compare	O
the	O
samples	O
.	O

To	O
establish	O
a	O
correlation	O
between	O
sialylation	O
status	O
and	O
glycoform	O
ratio	O
,	O
the	O
percentage	O
of	O
PrPSc	O
diglycosylated	O
forms	O
was	O
plotted	O
as	O
a	O
function	O
of	O
the	O
percentage	O
of	O
hypersialylated	O
isoforms	O
for	O
brain	O
-	O
and	O
dsPMCAb	O
-	O
derived	O
materials	O
(	O
Fig	O
.	O
3	O
).	O

This	O
plot	O
revealed	O
a	O
relationship	O
between	O
sialylation	O
status	O
and	O
glycoform	O
ratio	O
:	O
a	O
decrease	O
in	O
sialylation	O
levels	O
of	O
dsPMCA	O
-	O
derived	O
products	O
always	O
resulted	O
in	O
considerable	O
increase	O
in	O
recruitment	O
of	O
diglycosylated	O
forms	O
into	O
PrPSc	O
at	O
the	O
expense	O
of	O
mono	O
-	O
and	O
unglycosylated	O
glycoforms	O
.	O

This	O
correlation	O
was	O
observed	O
for	O
all	O
strains	O
tested	O
from	O
two	O
different	O
hosts	O
.	O

In	O
summary	O
,	O
the	O
changes	O
in	O
glycoform	O
ratios	O
in	O
response	O
to	O
changes	O
in	O
sialylation	O
status	O
support	O
the	O
hypothesis	O
that	O
negative	O
charges	O
of	O
sialic	O
acid	O
residues	O
create	O
electrostatic	O
repulsion	O
that	O
limits	O
recruitments	O
of	O
diglycosylated	O
glycoforms	O
.	O

Partial	O
desialylation	O
of	O
PrPC	O
abolishes	O
electrostatic	O
repulsion	O
,	O
and	O
as	O
a	O
result	O
,	O
the	O
proportion	O
of	O
diglycosylated	O
glycoforms	O
rises	O
.	O

The	O
following	O
testable	O
predictions	O
were	O
postulated	O
based	O
on	O
the	O
above	O
hypothesis	O
.	O

First	O
,	O
it	O
is	O
predicted	O
that	O
negative	O
selection	O
of	O
diglycosylated	O
forms	O
upon	O
conversion	O
of	O
PrPC	O
into	O
PrPSc	O
takes	O
place	O
,	O
i	O
.	O
e	O
the	O
proportion	O
of	O
diglycosylated	O
glycoforms	O
in	O
PrPSc	O
should	O
be	O
lower	O
than	O
that	O
in	O
PrPC	O
.	O

The	O
extent	O
of	O
negative	O
selection	O
should	O
depend	O
on	O
a	O
strain	O
-	O
specific	O
structure	O
and	O
degree	O
of	O
electrostatic	O
repulsion	O
.	O

For	O
strain	O
structures	O
with	O
close	O
proximity	O
of	O
glycan	O
moieties	O
,	O
the	O
negative	O
selection	O
should	O
be	O
the	O
strongest	O
.	O

Second	O
,	O
to	O
counteract	O
electrostatic	O
repulsion	O
,	O
it	O
is	O
predicted	O
that	O
negative	O
selection	O
of	O
hypersialylated	O
diglycosylated	O
isoforms	O
takes	O
place	O
in	O
addition	O
to	O
negative	O
selection	O
of	O
diglycosylated	O
forms	O
in	O
general	O
.	O

This	O
negative	O
selection	O
should	O
be	O
the	O
strongest	O
for	O
those	O
strains	O
that	O
show	O
the	O
strongest	O
negative	O
selection	O
of	O
diglycosylated	O
glycoforms	O
,	O
i	O
.	O
e	O
.	O
for	O
strains	O
with	O
the	O
highest	O
proportion	O
of	O
monoglycosylated	O
forms	O
.	O

Third	O
,	O
if	O
glycan	O
sialylation	O
indeed	O
creates	O
a	O
barrier	O
for	O
prion	B-GP
conversion	O
,	O
desialylation	O
of	O
PrPC	O
is	O
predicted	O
to	O
remove	O
this	O
barrier	O
and	O
lead	O
to	O
an	O
increase	O
in	O
prion	B-GP
amplification	O
rates	O
.	O

Negative	O
selection	O
of	O
diglycosylated	O
forms	O
upon	O
conversion	O
of	O
PrPC	O
into	O
PrPSc	O

To	O
test	O
whether	O
diglycosylated	O
forms	O
are	O
underrepresented	O
in	O
PrPSc	O
in	O
comparison	O
to	O
that	O
of	O
PrPC	O
,	O
glycoform	O
profiles	O
of	O
three	O
mouse	B-OG
strains	O
were	O
compared	O
to	O
that	O
of	O
mouse	B-OG
PrPC	O
(	O
Fig	O
.	O
1A	O
,	O
C	O
–	O
E	O
).	O

Consistent	O
with	O
previous	O
studies26	O
,	O
in	O
PrPC	O
the	O
diglycosylated	O
forms	O
were	O
found	O
to	O
be	O
predominant	O
,	O
while	O
unglycosylated	O
were	O
the	O
least	O
represented	O
(	O
Fig	O
.	O
1C	O
).	O

In	O
PrPSc	O
of	O
all	O
three	O
strains	O
,	O
the	O
proportion	O
of	O
di	O
-	O
versus	O
mono	O
-	O
and	O
unglycosylated	O
forms	O
shifted	O
in	O
favor	O
of	O
mono	O
-	O
and	O
unglycosylated	O
glycoforms	O
(	O
Fig	O
.	O
1A	O
,	O
B	O
).	O

This	O
result	O
argues	O
that	O
the	O
diglycosylated	O
form	O
is	O
subject	O
to	O
negative	O
selection	O
upon	O
conversion	O
of	O
PrPC	O
into	O
PrPSc	O
.	O

The	O
shift	O
was	O
most	O
substantial	O
for	O
the	O
RML	O
strain	O
,	O
illustrating	O
that	O
the	O
extent	O
of	O
a	O
negative	O
selection	O
is	O
determined	O
by	O
a	O
strain	O
-	O
specific	O
structure	O
.	O

Remarkably	O
,	O
upon	O
desialylation	O
of	O
the	O
substrate	O
,	O
the	O
dsPMCA	O
-	O
derived	O
products	O
showed	O
a	O
glycoform	O
profile	O
reminiscent	O
of	O
that	O
of	O
normal	O
substrate	O
,	O
where	O
diglycosylated	O
forms	O
were	O
predominant	O
(	O
Fig	O
.	O
1C	O
,	O
E	O
).	O

Moreover	O
,	O
in	O
dsPMCA	O
-	O
derived	O
products	O
all	O
three	O
strains	O
exhibited	O
a	O
very	O
similar	O
glycoform	O
profile	O
(	O
Fig	O
.	O
1E	O
).	O

These	O
results	O
demonstrate	O
that	O
reducing	O
the	O
content	O
of	O
sialic	O
acid	O
residues	O
on	O
PrPC	O
glycans	O
result	O
in	O
recruitment	O
of	O
the	O
three	O
glycoforms	O
into	O
PrPSc	O
proportionally	O
to	O
their	O
relative	O
populations	O
in	O
a	O
substrate	O
.	O

A	O
similar	O
trend	O
was	O
found	O
in	O
hamster	B-OG
strains	O
,	O
although	O
it	O
was	O
less	O
pronounced	O
(	O
Fig	O
.	O
1B	O
),	O
because	O
diglycosylated	O
forms	O
were	O
predominant	O
in	O
brain	O
-	O
derived	O
PrPSc	O
.	O

Together	O
,	O
these	O
results	O
illustrate	O
that	O
diglycosylated	O
glycoforms	O
are	O
underrepresented	O
in	O
PrPSc	O
,	O
the	O
extent	O
of	O
this	O
effect	O
is	O
strain	O
-	O
and	O
species	O
-	O
specific	O
,	O
and	O
that	O
PrPSc	O
structures	O
of	O
hamster	B-OG
strains	O
accommodate	O
diglycosylated	O
glycoforms	O
better	O
than	O
those	O
of	O
mouse	B-OG
strains	O
.	O

Negative	O
selection	O
of	O
hypersialylated	O
diglycosylated	O
isoforms	O

Among	O
three	O
glycoforms	O
,	O
diglycosylated	O
PrP	B-GP
exhibit	O
the	O
highest	O
charge	O
heterogeneity	O
,	O
as	O
it	O
can	O
accommodate	O
up	O
to	O
ten	O
negatively	O
charged	O
sialic	O
acid	O
residues	O
on	O
two	O
glycans	O
per	O
molecule17	O
.	O

As	O
a	O
result	O
,	O
the	O
charge	O
distribution	O
of	O
diglycosylated	O
isoforms	O
is	O
shifted	O
toward	O
acidic	O
pH	O
and	O
typically	O
extends	O
beyond	O
that	O
of	O
monoglycosylated	O
isoforms	O
,	O
which	O
accommodate	O
only	O
up	O
to	O
five	O
sialic	O
residues	O
per	O
molecule	O
.	O

The	O
extent	O
to	O
which	O
diglycosylated	O
isoforms	O
migrate	O
beyond	O
monoglycosylated	O
isoforms	O
toward	O
acidic	O
pH	O
reports	O
on	O
recruitment	O
of	O
hypersialylated	O
diglycosylated	O
isoforms	O
.	O

Careful	O
analysis	O
of	O
2D	O
results	O
revealed	O
that	O
in	O
brain	O
-	O
derived	O
PrPSc	O
hypersialylated	O
diglycosylated	O
molecules	O
were	O
recruited	O
in	O
a	O
strain	O
-	O
specific	O
manner	O
(	O
Fig	O
.	O
2	O
).	O

Hamster	B-OG
strains	O
showed	O
the	O
most	O
substantial	O
extension	O
of	O
diglycosylated	O
isoforms	O
toward	O
acidic	O
pH	O
relative	O
to	O
the	O
distribution	O
of	O
monoglycosylated	O
isoforms	O
(	O
Figs	O
2B	O
and	O
4	O
).	O

This	O
observation	O
suggests	O
that	O
hypersialylated	O
diglycosylated	O
molecules	O
are	O
well	O
represented	O
in	O
PrPSc	O
.	O

It	O
is	O
also	O
consistent	O
with	O
the	O
previous	O
results	O
showing	O
that	O
structures	O
of	O
hamster	B-OG
strains	O
accommodate	O
diglycosylated	O
PrP	B-GP
relatively	O
well	O
.	O

In	O
contrast	O
to	O
hamster	B-OG
strains	O
,	O
in	O
mouse	B-OG
strain	O
RML	O
the	O
distribution	O
of	O
diglycosylated	O
isoforms	O
does	O
not	O
extend	O
beyond	O
that	O
of	O
monoglycosylated	O
isoforms	O
at	O
acidic	O
pH	O
(	O
Figs	O
2A	O
and	O
4	O
).	O

This	O
indicates	O
that	O
a	O
negative	O
selection	O
of	O
hypersialylated	O
diglycosylated	O
molecules	O
takes	O
place	O
in	O
addition	O
to	O
a	O
general	O
negative	O
selection	O
of	O
diglycosylated	O
glycoforms	O
.	O

For	O
the	O
other	O
two	O
mouse	B-OG
strains	O
22L	O
and	O
ME7	O
,	O
the	O
diglycosylated	O
isoforms	O
extended	O
beyond	O
monoglycosylated	O
isoforms	O
at	O
acidic	O
pH	O
,	O
although	O
not	O
to	O
such	O
a	O
degree	O
as	O
those	O
of	O
hamster	B-OG
strains	O
(	O
Figs	O
2A	O
and	O
4	O
).	O

Overall	O
,	O
the	O
strain	O
-	O
specific	O
structures	O
that	O
tolerate	O
less	O
diglycosylated	O
forms	O
also	O
tend	O
to	O
exclude	O
hypersialylated	O
diglycosylated	O
forms	O
.	O

In	O
fact	O
,	O
plotting	O
strain	O
-	O
specific	O
percentage	O
of	O
diglycosylated	O
isoforms	O
versus	O
percentage	O
of	O
hypersialylated	O
isoforms	O
revealed	O
a	O
correlation	O
between	O
the	O
two	O
parameters	O
that	O
fits	O
well	O
to	O
a	O
linear	O
function	O
with	O
R	O
-	O
squared	O
value	O
of	O
0	O
.	O
89	O
(	O
Fig	O
.	O
3	O
).	O

Sialylation	O
of	O
PrPC	O
glycans	O
controls	O
replication	O
barrier	O

It	O
is	O
predicted	O
that	O
sialylation	O
of	O
PrPC	O
glycans	O
creates	O
a	O
replication	O
barrier	O
.	O

To	O
test	O
this	O
hypothesis	O
,	O
we	O
compared	O
amplification	O
rates	O
of	O
ME7	O
,	O
RML	O
and	O
22L	O
in	O
normal	O
versus	O
desialylated	O
substrates	O
using	O
PMCAb	O
and	O
dsPMCAb	O
,	O
respectively	O
.	O

For	O
comparing	O
amplification	O
rates	O
,	O
sets	O
of	O
serial	O
PMCAb	O
or	O
dsPMCAb	O
reactions	O
were	O
conducted	O
with	O
dilution	O
folds	O
between	O
serial	O
rounds	O
starting	O
from	O
1	O
:	O
3	O
and	O
higher	O
(	O
Fig	O
.	O
5	O
).	O

The	O
amplification	O
rate	O
is	O
defined	O
operationally	O
as	O
the	O
highest	O
dilution	O
between	O
serial	O
rounds	O
at	O
which	O
amplification	O
is	O
still	O
capable	O
of	O
compensating	O
the	O
effect	O
of	O
dilution	O
as	O
described	O
previously2930	O
.	O

In	O
desialylated	O
substrate	O
,	O
the	O
amplification	O
rate	O
increased	O
from	O
5	O
-	O
to	O
100	O
-	O
fold	O
for	O
ME7	O
and	O
from	O
10	O
-	O
to	O
at	O
least	O
500	O
-	O
fold	O
for	O
RML	O
and	O
22	O
L	O
.	O

Notably	O
,	O
consistent	O
with	O
previous	O
results	O
,	O
dsPMCAb	O
-	O
derived	O
products	O
showed	O
a	O
higher	O
proportion	O
of	O
diglycosylated	O
glycoforms	O
relative	O
to	O
PMCAb	O
-	O
derived	O
products	O
in	O
all	O
three	O
strains	O
(	O
Fig	O
.	O
5	O
).	O

Discussion	O

In	O
the	O
absence	O
of	O
posttranslational	O
modifications	O
,	O
prion	B-GP
protein	O
has	O
a	O
strong	O
positive	O
charge	O
at	O
physiological	O
pH	O
with	O
the	O
theoretical	O
pI	O
of	O
9	O
.	O
618	O
.	O

Sialylation	O
of	O
glycans	O
can	O
add	O
up	O
to	O
ten	O
negatively	O
charged	O
residues	O
and	O
shifts	O
the	O
pI	O
toward	O
acidic	O
pH	O
,	O
making	O
the	O
population	O
of	O
PrP	B-GP
molecules	O
highly	O
heterogeneous	O
with	O
respect	O
to	O
pI	O
and	O
the	O
net	O
charges	O
at	O
physiological	O
pH1718	O
.	O

In	O
PrPSc	O
particles	O
,	O
glycans	O
are	O
believed	O
to	O
be	O
directed	O
outward	O
where	O
the	O
terminal	O
sialic	O
acid	O
residues	O
create	O
a	O
dense	O
negative	O
charge	O
on	O
the	O
PrPSc	O
surface202122	O
.	O

The	O
current	O
study	O
proposed	O
that	O
due	O
to	O
electrostatic	O
repulsion	O
,	O
sialylation	O
of	O
glycans	O
creates	O
structural	O
constraints	O
for	O
PrPSc	O
replication	O
.	O

Several	O
testable	O
predictions	O
were	O
postulated	O
based	O
on	O
this	O
hypothesis	O
.	O

First	O
,	O
to	O
reduce	O
electrostatic	O
repulsion	O
,	O
it	O
is	O
expected	O
that	O
PrPC	O
with	O
a	O
heavy	O
sialylation	O
level	O
is	O
partially	O
excluded	O
from	O
the	O
conversion	O
.	O

This	O
could	O
be	O
achieved	O
via	O
(	O
i	O
)	O
selective	O
recruitment	O
of	O
mono	O
-	O
and	O
unglycosylated	O
PrPC	O
at	O
the	O
expense	O
of	O
diglycosylated	O
PrPC	O
and	O
(	O
ii	O
)	O
preferential	O
exclusion	O
of	O
hypersialylated	O
diglycosylated	O
PrPC	O
.	O

Depending	O
on	O
the	O
strain	O
-	O
specific	O
alignment	O
of	O
glycan	O
moieties	O
,	O
the	O
extent	O
of	O
this	O
effect	O
is	O
expected	O
to	O
be	O
strain	O
-	O
specific	O
(	O
Fig	O
.	O
6	O
).	O

Second	O
,	O
an	O
increase	O
in	O
the	O
rate	O
of	O
prion	B-GP
amplification	O
is	O
expected	O
when	O
the	O
constraints	O
imposed	O
by	O
sialic	O
acid	O
residues	O
are	O
relieved	O
by	O
employing	O
a	O
substrate	O
with	O
low	O
sialylation	O
levels	O
.	O

In	O
other	O
words	O
,	O
sialylation	O
of	O
PrPC	O
glycans	O
creates	O
a	O
replication	O
barrier	O
that	O
can	O
be	O
reduced	O
by	O
reducing	O
sialylation	O
levels	O
of	O
a	O
substrate	O
.	O

In	O
support	O
of	O
the	O
above	O
hypothesis	O
,	O
the	O
current	O
work	O
showed	O
that	O
the	O
relative	O
population	O
of	O
diglycosylated	O
forms	O
was	O
lower	O
in	O
PrPSc	O
than	O
those	O
in	O
PrPC	O
,	O
and	O
that	O
the	O
negative	O
selection	O
of	O
diglycosylated	O
forms	O
was	O
strain	O
-	O
specific	O
.	O

RML	O
showed	O
the	O
strongest	O
exclusion	O
of	O
diglycosylated	O
forms	O
.	O

The	O
hamster	B-OG
strains	O
(	O
263K	O
,	O
HY	O
,	O
DY	O
,	O
SSLOW	O
)	O
had	O
the	O
weakest	O
negative	O
selection	O
,	O
while	O
22L	O
and	O
ME7	O
strains	O
were	O
in	O
the	O
middle	O
.	O

Remarkably	O
,	O
in	O
PrPSc	O
generated	O
from	O
PrPC	O
that	O
was	O
partially	O
desialylated	O
,	O
the	O
relative	O
populations	O
of	O
glycofoms	O
were	O
found	O
to	O
be	O
very	O
similar	O
to	O
those	O
of	O
the	O
substrate	O
.	O

This	O
observation	O
illustrates	O
that	O
the	O
pressure	O
for	O
preferential	O
selection	O
of	O
un	O
-	O
and	O
monoglycosylated	O
forms	O
was	O
released	O
by	O
cleaving	O
sialic	O
acid	O
residues	O
.	O

In	O
addition	O
to	O
the	O
negative	O
selection	O
of	O
diglycosylated	O
forms	O
,	O
strains	O
with	O
the	O
strongest	O
structural	O
constraints	O
also	O
excluded	O
hypersialylated	O
molecules	O
.	O

RML	O
showed	O
the	O
strongest	O
negative	O
selection	O
of	O
diglycosylated	O
and	O
also	O
hypersialylated	O
forms	O
.	O

In	O
fact	O
,	O
a	O
strong	O
correlation	O
between	O
strain	O
-	O
specific	O
percentage	O
of	O
diglycosylated	O
forms	O
and	O
hypersialylated	O
forms	O
presented	O
in	O
Fig	O
.	O
3	O
for	O
brain	O
-	O
derived	O
material	O
suggests	O
that	O
the	O
negative	O
selection	O
of	O
both	O
is	O
attributed	O
to	O
the	O
same	O
structural	O
constrains	O
.	O

The	O
glycoform	O
ratios	O
within	O
PrPSc	O
are	O
believed	O
to	O
be	O
one	O
of	O
the	O
intrinsic	O
characteristics	O
of	O
prion	B-GP
strains	O
or	O
PrPSc	O
subtypes	O
(	O
reviewed	O
in31	O
).	O

In	O
fact	O
,	O
the	O
glycoform	O
ratios	O
have	O
been	O
used	O
for	O
strain	O
typing	O
and	O
classification	O
of	O
CJD	B-DS
type2425	O
.	O

It	O
was	O
not	O
clear	O
why	O
three	O
glycoforms	O
are	O
recruited	O
by	O
prion	B-GP
strains	O
in	O
different	O
proportions	O
even	O
within	O
the	O
same	O
host	O
.	O

The	O
current	O
work	O
demonstrates	O
that	O
the	O
strain	O
-	O
specific	O
ratio	O
of	O
the	O
three	O
glycoforms	O
is	O
a	O
result	O
of	O
negative	O
selection	O
of	O
heavily	O
sialylated	O
PrP	B-GP
molecules	O
.	O

The	O
extent	O
to	O
which	O
heavily	O
sialylated	O
PrP	B-GP
is	O
excluded	O
is	O
presumably	O
controlled	O
by	O
the	O
strain	O
-	O
specific	O
structure	O
of	O
PrPSc	O
and	O
relative	O
position	O
of	O
the	O
two	O
glycans	O
(	O
Fig	O
.	O
6	O
).	O

Remarkably	O
,	O
when	O
exposed	O
to	O
desialylated	O
substrate	O
,	O
prion	B-GP
strains	O
lose	O
strain	O
-	O
specific	O
selectivity	O
toward	O
different	O
glycoforms	O
and	O
the	O
glycoform	O
ratio	O
within	O
PrPSc	O
mirrors	O
that	O
of	O
PrPC	O
.	O

Brain	O
-	O
derived	O
PrPSc	O
of	O
different	O
strains	O
was	O
found	O
to	O
be	O
different	O
with	O
respect	O
to	O
its	O
sialylation	O
status	O
.	O

(	O
Fig	O
.	O
3	O
).	O

In	O
combination	O
with	O
substantial	O
strain	O
-	O
specific	O
differences	O
in	O
glycoform	O
ratios	O
,	O
these	O
differences	O
are	O
likely	O
to	O
produce	O
distinct	O
strain	O
-	O
specific	O
density	O
of	O
sialic	O
acid	O
residues	O
on	O
a	O
surface	O
of	O
PrPSc	O
particles	O
and	O
distinct	O
strain	O
-	O
specific	O
pIs	O
of	O
PrPSc	O
.	O

For	O
instance	O
,	O
at	O
physiological	O
pH	O
,	O
RML	O
PrPSc	O
particles	O
are	O
expected	O
to	O
have	O
net	O
positive	O
charges	O
,	O
whereas	O
PrPSc	O
particles	O
of	O
hamster	B-OG
strains	O
are	O
expected	O
to	O
be	O
charged	O
negatively	O
(	O
Fig	O
.	O
2	O
).	O

Terminal	O
sialic	O
acid	O
residues	O
constitute	O
key	O
elements	O
of	O
diverse	O
functional	O
epitopes	O
that	O
are	O
recognized	O
by	O
dozens	O
of	O
cell	O
receptors	O
including	O
siglecs	B-GP
and	O
selectins3233	B-GP
.	O

Through	O
these	O
functional	O
epitopes	O
,	O
sialylation	O
of	O
glycoproteins	O
mediate	O
their	O
interaction	O
with	O
cells	O
of	O
the	O
innate	O
immune	O
system	O
and	O
microglia34	O
.	O

These	O
interactions	O
define	O
the	O
ultimate	O
fate	O
of	O
mammalian	O
cells	O
,	O
glycoproteins	O
in	O
circulation	O
and	O
microbial	O
pathogens3536	O
.	O

It	O
remains	O
to	O
be	O
established	O
whether	O
strain	O
-	O
specific	O
differences	O
in	O
PrPSc	O
sialylation	O
play	O
any	O
role	O
in	O
defining	O
strain	O
-	O
specific	O
neurotropism	O
and	O
lymphotropism	O
.	O

The	O
current	O
study	O
illustrates	O
that	O
PrPSc	O
glycoform	O
ratio	O
is	O
not	O
only	O
controlled	O
by	O
strain	O
or	O
host	O
,	O
but	O
also	O
by	O
sialylation	O
level	O
of	O
PrPC	O
.	O

As	O
such	O
,	O
experiments	O
on	O
infecting	O
new	O
hosts	O
or	O
cell	O
lines	O
with	O
unknown	O
PrPC	O
sialylation	O
status	O
should	O
be	O
interpreted	O
with	O
great	O
care	O
.	O

In	O
previous	O
studies	O
,	O
shifts	O
in	O
glycoform	O
ratios	O
toward	O
diglycosylated	O
glycoforms	O
were	O
observed	O
in	O
scrapie	B-DS
-	O
infected	O
cells	O
treated	O
with	O
swainsonine	O
,	O
a	O
compound	O
that	O
inhibits	O
complex	O
glycosylation3738	O
.	O

It	O
was	O
concluded	O
that	O
selection	O
of	O
minor	O
strain	O
variants	O
or	O
structural	O
mutants	O
occurred3738	O
.	O

Because	O
treatment	O
with	O
swainsonine	O
blocks	O
complex	O
glycosylation	O
including	O
sialylation	O
,	O
it	O
is	O
expected	O
that	O
the	O
glycoform	O
ratios	O
would	O
change	O
in	O
favor	O
of	O
diglycosylated	O
forms	O
regardless	O
whether	O
selection	O
of	O
a	O
new	O
variants	O
occurs	O
or	O
not	O
.	O

The	O
current	O
work	O
predicts	O
that	O
if	O
the	O
PrPSc	O
glycoform	O
ratio	O
changes	O
upon	O
infecting	O
a	O
new	O
host	O
,	O
this	O
change	O
is	O
indicative	O
of	O
an	O
altered	O
sialylation	O
status	O
of	O
PrPC	O
and	O
,	O
specifically	O
,	O
a	O
shift	O
toward	O
diglycosylated	O
forms	O
would	O
suggest	O
a	O
reduced	O
sialylation	O
level	O
of	O
PrPC	O
.	O

The	O
hypothesis	O
presented	O
in	O
the	O
current	O
work	O
introduces	O
new	O
constraints	O
for	O
establishing	O
PrPSc	O
structure	O
.	O

To	O
account	O
for	O
the	O
negative	O
selection	O
of	O
diglycosylated	O
/	O
hypersialylated	O
PrPC	O
,	O
glycans	O
of	O
the	O
neighboring	O
PrP	B-GP
molecules	O
should	O
be	O
aligned	O
in	O
close	O
proximity	O
to	O
each	O
other	O
within	O
assembled	O
PrPSc	O
particles	O
.	O

The	O
average	O
volume	O
and	O
dimension	O
of	O
glycan	O
moieties	O
should	O
be	O
taken	O
into	O
consideration	O
for	O
estimating	O
the	O
proper	O
folding	O
pattern	O
and	O
the	O
number	O
of	O
intramolecular	O
rings	O
or	O
layers	O
acquired	O
by	O
a	O
single	O
polypeptide	O
chain	O
within	O
intact	O
PrPSc	O
.	O

More	O
substantial	O
clashes	O
between	O
glycans	O
of	O
neighboring	O
diglycosylated	O
forms	O
are	O
expected	O
for	O
strains	O
or	O
PrPSc	O
subtypes	O
with	O
predominantly	O
monoglycosylated	O
forms	O
,	O
such	O
as	O
sporadic	O
CJD	B-DS
,	O
in	O
comparison	O
with	O
the	O
strains	O
where	O
diglycosylated	O
forms	O
are	O
predominant	O
,	O
such	O
as	O
new	O
variant	O
CJD24	O
(	O
Fig	O
.	O
6	O
).	O

For	O
the	O
three	O
mouse	B-OG
strains	O
tested	O
in	O
the	O
current	O
study	O
,	O
partial	O
desialylation	O
of	O
PrPC	O
increased	O
the	O
replication	O
rates	O
by	O
20	O
–	O
50	O
fold	O
(	O
Fig	O
.	O
5	O
).	O

These	O
results	O
suggested	O
that	O
sialylation	O
of	O
PrP	B-GP
glycans	O
contributes	O
to	O
a	O
replication	O
barrier	O
.	O

An	O
alternative	O
explanation	O
is	O
that	O
sialidase	B-GP
treatment	O
of	O
NBH	O
had	O
an	O
effect	O
other	O
than	O
on	O
PrPC	O
.	O

While	O
this	O
seems	O
to	O
be	O
unlikely	O
,	O
this	O
possibility	O
should	O
not	O
be	O
discarded	O
completely	O
.	O

In	O
previous	O
studies	O
,	O
partial	O
desialylation	O
of	O
PrPC	O
was	O
also	O
found	O
to	O
considerably	O
reduce	O
the	O
barrier	O
in	O
cross	O
-	O
seeded	O
PMCAb	O
reactions18	O
.	O

Together	O
,	O
these	O
data	O
suggest	O
that	O
the	O
replication	O
barrier	O
attributable	O
to	O
glycan	O
sialylation	O
is	O
universal	O
,	O
i	O
.	O
e	O
.	O
it	O
might	O
not	O
only	O
control	O
the	O
rate	O
of	O
prion	B-GP
replication	O
within	O
the	O
same	O
host	O
but	O
also	O
the	O
barrier	O
associated	O
with	O
prion	B-GP
transmission	O
between	O
different	O
species	O
.	O

There	O
might	O
be	O
several	O
components	O
that	O
underlie	O
a	O
replication	O
barrier	O
attributable	O
to	O
sialylation	O
.	O

First	O
,	O
electrostatic	O
repulsion	O
between	O
negatively	O
charged	O
sialic	O
acid	O
residues	O
on	O
glycans	O
of	O
PrPSc	O
and	O
PrPC	O
limits	O
the	O
range	O
of	O
PrPC	O
molecules	O
suitable	O
for	O
conversion	O
to	O
those	O
with	O
moderate	O
sialylation	O
levels	O
.	O

Second	O
,	O
even	O
for	O
the	O
PrPC	O
molecules	O
that	O
are	O
suitable	O
for	O
conversion	O
,	O
electrostatic	O
repulsion	O
of	O
surface	O
glycans	O
might	O
slow	O
down	O
the	O
rates	O
of	O
PrPC	O
binding	O
to	O
PrPSc	O
and	O
PrPC	O
conversion	O
.	O

Third	O
,	O
electrostatic	O
repulsion	O
between	O
surface	O
glycans	O
of	O
nascent	O
PrPSc	O
has	O
a	O
negative	O
impact	O
on	O
thermodynamic	O
stability	O
of	O
PrPSc	O
particles	O
,	O
the	O
effect	O
that	O
has	O
to	O
be	O
counteracted	O
by	O
other	O
forces	O
that	O
stabilize	O
packing	O
of	O
polypeptide	O
chains	O
within	O
PrPSc	O
particles	O
.	O

Notably	O
,	O
while	O
thermodynamic	O
stability	O
of	O
PrPSc	O
varies	O
depending	O
on	O
strain	O
-	O
specific	O
structure6293940	O
,	O
the	O
range	O
of	O
strain	O
-	O
specific	O
thermodynamic	O
stabilities	O
of	O
PrPSc	O
is	O
typically	O
lower	O
than	O
those	O
of	O
amyloid	O
fibrils	O
generated	O
in	O
vitro	O
using	O
recombinant	O
PrP4142	O
.	O

In	O
part	O
,	O
this	O
could	O
be	O
due	O
to	O
electrostatic	O
repulsion	O
between	O
sialylated	O
glycans	O
that	O
recombinant	O
PrP	B-GP
lacks	O
.	O

According	O
to	O
the	O
hypothesis	O
introduced	O
here	O
,	O
the	O
same	O
structural	O
constraints	O
account	O
for	O
at	O
least	O
part	O
of	O
the	O
replication	O
barrier	O
and	O
the	O
degree	O
to	O
which	O
diglycosylated	O
forms	O
are	O
excluded	O
.	O

If	O
this	O
is	O
true	O
,	O
there	O
should	O
be	O
a	O
correlation	O
between	O
strain	O
-	O
specific	O
glycoform	O
ratios	O
and	O
the	O
efficiency	O
of	O
prion	B-GP
replication	O
.	O

Indeed	O
,	O
mouse	B-OG
strains	O
have	O
a	O
high	O
proportion	O
of	O
monoglycosylated	O
glycoforms	O
and	O
also	O
slow	O
replication	O
rates	O
in	O
PMCA	O
.	O

Similar	O
correlations	O
between	O
glycoform	O
ratio	O
and	O
the	O
replication	O
efficiency	O
was	O
observed	O
for	O
two	O
forms	O
of	O
CJD	B-DS
.	O

It	O
is	O
known	O
that	O
nvCJD	O
,	O
which	O
is	O
predominantly	O
diglycosylated	O
,	O
replicates	O
in	O
PMCA	O
with	O
a	O
much	O
better	O
efficiency	O
than	O
sCJD	O
,	O
which	O
is	O
predominantly	O
monoglycosylated434445	O
.	O

However	O
,	O
not	O
all	O
strains	O
with	O
predominantly	O
diglycosylated	O
glycoforms	O
display	O
fast	O
replication	O
rates	O
suggesting	O
that	O
factors	O
other	O
than	O
sialylation	O
contribute	O
to	O
the	O
replication	O
barrier	O
.	O

For	O
instance	O
,	O
hamster	B-OG
-	O
adapted	O
strains	O
DY	O
,	O
139H	O
and	O
22AH	O
are	O
predominantly	O
diglycosylated	O
,	O
but	O
replicate	O
very	O
slowly39	O
.	O

Methods	O

Normal	O
and	O
scrapie	B-DS
brain	O
materials	O

Weanling	O
Golden	O
Syrian	B-OG
hamsters	I-OG
or	O
C57BL	B-OG
/	I-OG
6NHsd	I-OG
mice	I-OG
were	O
inoculated	O
intracerebrally	O
under	O
2	O
%	O
O2	O
/	O
4	O
MAC	O
isoflurane	O
anesthesia	O
using	O
scrapie	B-DS
brain	O
homogenates	O
of	O
hamster	B-OG
-	O
or	O
mouse	B-OG
-	O
adapted	O
strains	O
,	O
respectively	O
.	O

For	O
the	O
synthetic	O
strain	O
SSLOW	O
,	O
animals	B-OG
of	O
fourth	O
serial	O
SSLOW	O
passage	O
were	O
used	O
for	O
analysis46	O
.	O

Animals	B-OG
were	O
euthanized	O
at	O
the	O
terminal	O
stage	O
of	O
the	O
disease	O
and	O
brains	O
were	O
collected	O
for	O
subsequent	O
analysis	O
.	O

This	O
study	O
was	O
carried	O
out	O
in	O
strict	O
accordance	O
with	O
the	O
recommendations	O
in	O
the	O
Guide	O
for	O
the	O
Care	O
and	O
Use	O
of	O
Laboratory	O
Animals	B-OG
of	O
the	O
National	O
Institutes	O
of	O
Health	O
.	O

The	O
animal	B-OG
protocol	O
was	O
approved	O
by	O
the	O
Institutional	O
Animal	O
Care	O
and	O
Use	O
Committee	O
of	O
the	O
University	O
of	O
Maryland	O
,	O
Baltimore	O
(	O
Assurance	O
Number	O
A32000	O
-	O
01	O
;	O
Permit	O
Number	O
:	O
0215002	O
).	O

Protein	O
misfolding	O
cyclic	O
amplification	O
with	O
beads	O
(	O
PMCAb	O
)	O
and	O
PMCAb	O
in	O
desialylated	O
substrate	O
(	O
dsPMCAb	O
)	O

10	O
%	O
normal	O
brain	O
homogenate	O
(	O
NBH	O
)	O
from	O
healthy	O
hamsters	B-OG
or	O
mice	B-OG
was	O
prepared	O
as	O
described	O
previously47	O
.	O

To	O
produce	O
desialylated	O
substrates	O
for	O
dsPMCAb	O
,	O
10	O
%	O
NBH	O
was	O
treated	O
with	O
Arthrobacter	B-OG
ureafaciens	I-OG
sialidase	B-GP
(	O
cat	O
#	O
P0722L	O
,	O
New	O
England	O
Biolabs	O
,	O
Ipswich	O
,	O
MA	O
)	O
as	O
follows	O
.	O

After	O
preclearance	O
of	O
NBH	O
at	O
500	O
×	O
g	O
for	O
2	O
min	O
and	O
addition	O
of	O
the	O
enzyme	O
buffer	O
supplied	O
with	O
the	O
manufacturer	O
to	O
supernatant	O
200	O
units	O
/	O
mL	O
of	O
sialidase	B-GP
were	O
added	O
to	O
the	O
supernatant	O
,	O
incubated	O
on	O
a	O
rotator	O
at	O
37	O
°	O
C	O
for	O
5	O
h	O
and	O
the	O
resulting	O
material	O
referred	O
to	O
as	O
dsNBH	O
substrate	O
used	O
in	O
dsPMCAb	O
.	O

PMCAb	O
and	O
dsPMCAb	O
reactions	O
were	O
conducted	O
as	O
previously	O
described1848	O
using	O
Misonix	O
S	O
-	O
4000	O
microplate	O
horn	O
(	O
Qsonica	O
LLC	O
,	O
Newtown	O
,	O
CT	O
)	O
in	O
the	O
presence	O
of	O
two	O
2	O
/	O
32	O
”	O
Teflon	O
beads	O
in	O
each	O
tube	O
(	O
McMaster	O
-	O
Carr	O
,	O
Elmhurst	O
,	O
IL	O
).	O

One	O
round	O
consisted	O
of	O
20	O
sec	O
sonications	O
delivered	O
at	O
170	O
W	O
energy	O
output	O
applied	O
every	O
20	O
min	O
during	O
a	O
24	O
hour	O
period	O
.	O

For	O
each	O
subsequent	O
round	O
,	O
10	O
μl	O
(	O
for	O
hamster	B-OG
strains	O
)	O
or	O
20	O
μl	O
(	O
for	O
mouse	B-OG
strains	O
)	O
of	O
the	O
reaction	O
products	O
from	O
the	O
previous	O
round	O
were	O
mixed	O
with	O
90	O
or	O
80	O
μl	O
of	O
fresh	O
substrate	O
,	O
respectively	O
,	O
or	O
as	O
specified	O
for	O
the	O
amplification	O
rate	O
experiment	O
.	O

Western	O
blots	O

10	O
μL	O
of	O
10	O
%	O
brain	O
homogenate	O
or	O
dsPMCAb	O
-	O
derived	O
materials	O
were	O
supplemented	O
with	O
5	O
μL	O
1	O
%	O
SDS	O
and	O
5	O
μL	O
proteinase	B-GP
K	I-GP
(	O
cat	O
.	O
#	O
P8107S	O
,	O
New	O
England	O
Biolabs	O
,	O
Ipswich	O
,	O
MA	O
),	O
to	O
a	O
final	O
concentration	O
of	O
0	O
.	O
25	O
%	O
SDS	O
and	O
25	O
μg	O
/	O
mL	O
proteinase	B-GP
K	I-GP
,	O
and	O
incubated	O
at	O
37	O
°	O
C	O
for	O
1	O
hour	O
.	O

Then	O
,	O
SDS	O
sample	O
buffer	O
was	O
added	O
,	O
samples	O
were	O
boiled	O
for	O
10	O
minutes	O
and	O
loaded	O
onto	O
NuPage	O
12	O
%	O
BisTris	O
gel	O
(	O
cat	O
.	O
#	O
NP0341BOX	O
,	O
Life	O
Technologies	O
,	O
Carlsbad	O
,	O
CA	O
),	O
transferred	O
to	O
PVDF	O
membrane	O
,	O
and	O
probed	O
with	O
3F4	O
(	O
cat	O
.	O
#	O
SIG	O
-	O
39600	O
,	O
Covance	O
)	O
or	O
Ab3531	O
antibody	B-GP
(	O
Abcam	O
).	O

Preparation	O
of	O
brain	O
-	O
and	O
dsPMCAb	O
-	O
derived	O
materials	O
for	O
2D	O

10	O
%	O
(	O
wt	O
/	O
vol	O
)	O
of	O
scrapie	B-DS
brain	O
homogenates	O
were	O
prepared	O
in	O
PBS	O
using	O
glass	O
/	O
Teflon	O
homogenizers	O
attached	O
to	O
a	O
cordless	O
12	O
V	O
compact	O
drill	O
(	O
Ryobi	O
)	O
as	O
previously	O
described46	O
.	O

For	O
2D	O
electrophoresis	O
of	O
brain	O
-	O
derived	O
materials	O
,	O
an	O
aliquot	O
of	O
10	O
%	O
(	O
wt	O
/	O
vol	O
)	O
homogenate	O
was	O
diluted	O
with	O
nine	O
volumes	O
of	O
1	O
%	O
(	O
vol	O
/	O
vol	O
)	O
Triton	O
X	O
-	O
100	O
in	O
PBS	O
,	O
sonicated	O
for	O
30	O
s	O
inside	O
a	O
Misonix	O
S	O
-	O
4000	O
microplate	O
horn	O
(	O
Qsonica	O
LLC	O
,	O
Newtown	O
,	O
CT	O
),	O
and	O
treated	O
with	O
25	O
μg	O
/	O
mL	O
proteinase	B-GP
K	I-GP
for	O
30	O
min	O
at	O
37	O
°	O
C	O
.	O
dsPMCAb	O
materials	O
were	O
treated	O
with	O
25	O
μg	O
/	O
mL	O
PK	O
in	O
the	O
presence	O
of	O
0	O
.	O
25	O
%	O
SDS	O
for	O
60	O
min	O
at	O
37	O
°	O
C	O
.	O

Resulting	O
brain	O
and	O
dsPMCAb	O
samples	O
were	O
supplemented	O
with	O
4xSDS	O
loading	O
buffer	O
,	O
heated	O
for	O
10	O
min	O
in	O
a	O
boiling	O
water	O
bath	O
and	O
processed	O
for	O
2D	O
electrophoresis	O
as	O
described	O
below	O
.	O

2D	O
electrophoresis	O

Samples	O
of	O
25	O
μL	O
volume	O
prepared	O
in	O
loading	O
buffer	O
as	O
described	O
above	O
were	O
solubilized	O
for	O
1	O
h	O
at	O
room	O
temperature	O
in	O
200	O
μL	O
solubilization	O
buffer	O
(	O
8	O
M	O
Urea	O
,	O
2	O
%	O
(	O
wt	O
/	O
vol	O
)	O
CHAPS	O
,	O
5	O
mM	O
TBP	O
,	O
20	O
mM	O
TrisHCl	O
pH	O
8	O
.	O
0	O
),	O
then	O
alkylated	O
by	O
adding	O
7	O
μL	O
of	O
0	O
.	O
5	O
M	O
iodoacetamide	O
and	O
incubated	O
for	O
1	O
h	O
at	O
room	O
temperature	O
.	O

Then	O
,	O
1150	O
μL	O
of	O
ice	O
-	O
cold	O
methanol	O
was	O
added	O
and	O
samples	O
were	O
incubated	O
for	O
2	O
h	O
at	O
−	O
20	O
°	O
C	O
.	O

After	O
centrifugation	O
at	O
16	O
,	O
000	O
g	O
at	O
4	O
°	O
C	O
,	O
supernatant	O
was	O
discarded	O
and	O
the	O
pellet	O
was	O
re	O
-	O
solubilized	O
in	O
160	O
μL	O
rehydration	O
buffer	O
(	O
7	O
M	O
urea	O
,	O
2	O
M	O
thiourea	O
,	O
1	O
%	O
(	O
wt	O
/	O
vol	O
)	O
DTT	O
,	O
1	O
%	O
(	O
wt	O
/	O
vol	O
)	O
CHAPS	O
,	O
1	O
%	O
(	O
wt	O
/	O
vol	O
)	O
Triton	O
X	O
-	O
100	O
,	O
1	O
%	O
(	O
vol	O
/	O
vol	O
)	O
ampholyte	O
,	O
trace	O
amount	O
of	O
Bromophenol	O
Blue	O
).	O

Fixed	O
immobilized	O
pre	O
-	O
cast	O
IPG	O
strips	O
with	O
a	O
non	O
-	O
linear	O
pH	O
gradient	O
3	O
–	O
10	O
used	O
in	O
the	O
previous	O
study18	O
were	O
replaced	O
by	O
fixed	O
immobilized	O
pre	O
-	O
cast	O
IPG	O
strips	O
with	O
a	O
linear	O
pH	O
gradient	O
3	O
–	O
10	O
(	O
cat	O
.	O
#	O
ZM0018	O
,	O
Life	O
Technologies	O
,	O
Carlsbad	O
,	O
CA	O
)	O
that	O
provide	O
a	O
better	O
resolution	O
of	O
charge	O
isoforms	O
.	O

Strips	O
were	O
rehydrated	O
in	O
155	O
μL	O
of	O
the	O
resulting	O
mixture	O
overnight	O
at	O
room	O
temperature	O
inside	O
IPG	O
Runner	O
cassettes	O
(	O
cat	O
.	O
#	O
ZM0003	O
,	O
Life	O
Technologies	O
).	O

Isoelectrofocusing	O
(	O
first	O
dimension	O
separation	O
)	O
was	O
performed	O
at	O
room	O
temperature	O
with	O
rising	O
voltage	O
(	O
175V	O
for	O
15	O
minutes	O
,	O
then	O
175	O
–	O
2	O
,	O
000V	O
linear	O
gradient	O
for	O
45	O
minutes	O
,	O
then	O
2	O
,	O
000	O
V	O
for	O
30	O
minutes	O
)	O
on	O
Life	O
Technologies	O
Zoom	O
Dual	O
Power	O
Supply	O
,	O
using	O
the	O
XCell	O
SureLock	O
Mini	O
-	O
Cell	O
Electrophoresis	O
System	O
(	O
cat	O
.	O
#	O
EI0001	O
,	O
Life	O
Technologies	O
).	O

The	O
IPG	O
strips	O
were	O
then	O
equilibrated	O
for	O
15	O
minutes	O
consecutively	O
in	O
(	O
i	O
)	O
6	O
M	O
Urea	O
,	O
20	O
%	O
(	O
vol	O
/	O
vol	O
)	O
glycerol	O
,	O
2	O
%	O
SDS	O
,	O
375	O
mM	O
Tris	O
-	O
HCl	O
pH	O
8	O
.	O
8	O
,	O
130	O
mM	O
DTT	O
and	O
(	O
ii	O
)	O
6	O
M	O
Urea	O
,	O
20	O
%	O
(	O
vol	O
/	O
vol	O
)	O
glycerol	O
,	O
2	O
%	O
SDS	O
,	O
375	O
mM	O
Tris	O
-	O
HCl	O
pH	O
8	O
.	O
8	O
,	O
135	O
mM	O
iodoacetamide	O
,	O
and	O
loaded	O
on	O
4	O
–	O
12	O
%	O
Bis	O
-	O
Tris	O
ZOOM	O
SDS	O
-	O
PAGE	O
pre	O
-	O
cast	O
gels	O
(	O
cat	O
.	O
#	O
NP0330BOX	O
,	O
Life	O
Technologies	O
).	O

For	O
the	O
second	O
dimension	O
,	O
SDS	O
-	O
PAGE	O
was	O
performed	O
for	O
1	O
h	O
at	O
170	O
V	O
.	O

Immunoblotting	O
was	O
performed	O
as	O
described	O
elsewhere	O
,	O
blots	O
were	O
stained	O
using	O
3F4	O
or	O
Ab3531	O
antibody	B-GP
.	O

Western	O
blot	O
densitometry	O
analysis	O

1D	O
or	O
2D	O
western	O
blot	O
signal	O
intensity	O
was	O
digitized	O
for	O
densitometry	O
analysis	O
using	O
AlphaView	O
software	O
(	O
ProteinSimple	O
,	O
San	O
Jose	O
,	O
CA	O
).	O

For	O
densitometry	O
analysis	O
of	O
the	O
glycoform	O
distribution	O
(	O
expressed	O
as	O
a	O
percentage	O
of	O
the	O
diglycosylated	O
form	O
),	O
target	O
bands	O
were	O
selected	O
using	O
a	O
uniform	O
rectangular	O
sampling	O
area	O
that	O
encompassed	O
the	O
band	O
of	O
interest	O
.	O

Background	O
optical	O
density	O
of	O
an	O
equal	O
area	O
from	O
the	O
same	O
blot	O
was	O
determined	O
and	O
subsequently	O
subtracted	O
from	O
the	O
density	O
of	O
the	O
bands	O
.	O

At	O
least	O
three	O
measurements	O
from	O
independent	O
gel	O
loadings	O
were	O
used	O
for	O
each	O
sample	O
for	O
calculating	O
mean	O
and	O
standard	O
deviations	O
.	O

For	O
analysis	O
of	O
sialylation	O
,	O
2D	O
blots	O
were	O
aligned	O
horizontally	O
and	O
a	O
line	O
drawn	O
at	O
pI	O
7	O
.	O
5	O
was	O
used	O
to	O
arbitrarily	O
separate	O
charge	O
isoforms	O
into	O
hypersialylated	O
and	O
hyposialylated	O
.	O

In	O
the	O
software	O
window	O
,	O
a	O
rectangle	O
was	O
drawn	O
to	O
confine	O
the	O
spots	O
of	O
interest	O
,	O
and	O
the	O
densities	O
measured	O
.	O

The	O
intensity	O
of	O
an	O
equal	O
background	O
area	O
from	O
the	O
same	O
blot	O
was	O
subtracted	O
before	O
calculations	O
were	O
done	O
.	O

The	O
acquired	O
spot	O
ensemble	O
intensities	O
were	O
used	O
to	O
calculate	O
percentage	O
of	O
“	O
hypersialylated	O
”	O
isoforms	O
.	O

Hypersialylated	O
isoforms	O
were	O
defined	O
operationally	O
as	O
all	O
isoforms	O
located	O
to	O
the	O
left	O
of	O
the	O
pI7	O
.	O
5	O
line	O
;	O
the	O
percentage	O
of	O
hypersialylated	O
isoforms	O
was	O
calculated	O
assuming	O
the	O
total	O
intensity	O
of	O
all	O
isoforms	O
as	O
100	O
%.	O

For	O
generating	O
glycoform	O
profiles	O
or	O
sialylation	O
profiles	O
for	O
di	O
-	O
and	O
monoglycosylated	O
glycoforms	O
,	O
densitometry	O
analysis	O
of	O
1D	O
or	O
2D	O
blots	O
,	O
respectively	O
,	O
was	O
performed	O
using	O
the	O
“	O
Lane	O
profile	O
”	O
function	O
in	O
the	O
AlphaView	O
program	O
.	O

For	O
data	O
presented	O
in	O
normalized	O
format	O
(	O
Fig	O
.	O
4	O
),	O
the	O
highest	O
curve	O
signal	O
value	O
was	O
taken	O
as	O
100	O
%.	O

Additional	O
Information	O

How	O
to	O
cite	O
this	O
article	O
:	O
Katorcha	O
,	O
E	O
.	O
et	O
al	O
.	O
Sialylation	O
of	O
the	O
prion	B-GP
protein	O
glycans	O
controls	O
prion	B-GP
replication	O
rate	O
and	O
glycoform	O
ratio	O
.	O
Sci	O
.	O

Rep	O
.	O
5	O
,	O
16912	O
;	O
doi	O
:	O
10	O
.	O
1038	O
/	O
srep16912	O
(	O
2015	O
).	O

Author	O
Contributions	O
E	O
.	O
K	O
.	O
and	O
I	O
.	O
V	O
.	O
B	O
.	O
conceived	O
the	O
experiments	O
;	O
E	O
.	O
K	O
.,	O
N	O
.	O
M	O
.	O
and	O
R	O
.	O
S	O
.	O
conducted	O
the	O
experiments	O
;	O
E	O
.	O
K	O
.	O
and	O
I	O
.	O
V	O
.	O
B	O
.	O
analyzed	O
the	O
results	O
.	O

E	O
.	O
K	O
.	O
and	O
I	O
.	O
V	O
.	O
B	O
.	O
wrote	O
the	O
manuscript	O
.	O

All	O
authors	O
reviewed	O
the	O
manuscript	O
.	O

Western	O
blots	O
of	O
scrapie	O
brain	O
-	O
derived	O
(	O
SBH	O
)	O
and	O
dsPMCAb	O
-	O
derived	O
materials	O
of	O
mouse	O
strains	O
ME7	O
,	O
22L	O
and	O
RML	O
(	O
A	O
)	O
or	O
hamster	O
strains	O
263K	O
,	O
HY	O
,	O
DY	O
,	O
SSLOW	O
(	O
B	O
).	O

For	O
producing	O
dsPMCA	O
-	O
derived	O
material	O
,	O
dsPMCAb	O
reactions	O
were	O
seeded	O
with	O
brain	O
material	O
and	O
propagated	O
in	O
serial	O
dsPMCA	O
to	O
the	O
final	O
dilution	O
of	O
brain	O
material	O
108	O
-	O
fold	O
.	O

Mouse	O
or	O
hamster	O
normal	O
brain	O
homogenates	O
(	O
MoNBH	O
or	O
HaNBH	O
,	O
respectively	O
)	O
are	O
shown	O
as	O
references	O
.	O

All	O
samples	O
except	O
MoNBH	O
and	O
HaNBH	O
were	O
treated	O
with	O
PK	O
.	O

Mouse	O
and	O
hamster	O
materials	O
were	O
stained	O
with	O
Ab3531	O
or	O
3F4	O
antibodies	O
,	O
respectively	O
.	O

Black	O
triangles	O
,	O
white	O
triangles	O
and	O
arrows	O
mark	O
di	O
-,	O
mono	O
-	O
and	O
non	O
-	O
glycosylated	O
glycoforms	O
,	O
respectively	O
.	O

Glycoform	O
profiles	O
of	O
mouse	O
PrPC	O
from	O
three	O
independent	O
normal	O
brain	O
materials	O
(	O
C	O
),	O
scrapie	O
brain	O
-	O
derived	O
material	O
(	O
D	O
)	O
or	O
dsPMCAb	O
-	O
derived	O
material	O
(	O
E	O
)	O
for	O
ME7	O
(	O
solid	O
lines	O
),	O
22L	O
(	O
dotted	O
lines	O
)	O
and	O
RML	O
(	O
dashed	O
lines	O
).	O

Profiles	O
were	O
built	O
and	O
normalized	O
as	O
described	O
in	O
Materials	O
and	O
Methods	O
using	O
results	O
of	O
1D	O
Western	O
blots	O
.	O

2D	O
analysis	O
of	O
charge	O
distribution	O
of	O
scrapie	O
brain	O
-	O
and	O
dsPMCAb	O
-	O
derived	O
materials	O
for	O
mouse	O
strains	O
RML	O
,	O
22L	O
and	O
ME7	O
(	O
A	O
)	O
and	O
hamster	O
strains	O
263K	O
,	O
HY	O
,	O
DY	O
and	O
SSLOW	O
(	O
B	O
).	O

dsPMCAb	O
-	O
derived	O
materials	O
were	O
produced	O
as	O
described	O
in	O
the	O
legend	O
to	O
Fig	O
.	O
1	O
.	O

The	O
dash	O
line	O
shows	O
position	O
of	O
pI	O
7	O
.	O
5	O
and	O
arbitrary	O
divides	O
“	O
hypersialylated	O
”	O
and	O
“	O
hyposialylated	O
”	O
PrP	O
molecules	O
.	O

Appearance	O
of	O
more	O
than	O
one	O
charge	O
isoform	O
for	O
unglycosylated	O
PrP	O
is	O
attributed	O
to	O
structural	O
heterogeneity	O
of	O
the	O
GPI	O
anchor8	O
.	O

Nevertheless	O
,	O
due	O
to	O
sialylation	O
of	O
glycans	O
,	O
monoglycosylated	O
PrPs	O
can	O
carry	O
up	O
to	O
five	O
negatively	O
charged	O
sialic	O
acid	O
residues	O
,	O
while	O
diglycosylated	O
PrPs	O
–	O
up	O
to	O
ten	O
sialic	O
acid	O
residues	O
.	O

As	O
a	O
result	O
,	O
the	O
distribution	O
of	O
charge	O
isoform	O
is	O
shifted	O
toward	O
acidic	O
pH	O
for	O
monoglycosylated	O
PrPs	O
and	O
even	O
more	O
so	O
for	O
diglycosylated	O
PrPs	O
,	O
relative	O
to	O
that	O
of	O
unglycosylated	O
PrPs	O
.	O

All	O
samples	O
were	O
treated	O
with	O
PK	O
.	O

Mouse	O
and	O
hamster	O
materials	O
were	O
stained	O
with	O
Ab3531	O
or	O
3F4	O
antibodies	O
,	O
respectively	O
.	O

Black	O
triangles	O
,	O
white	O
triangles	O
and	O
arrows	O
mark	O
di	O
-,	O
mono	O
-	O
and	O
non	O
-	O
glycosylated	O
glycoforms	O
,	O
respectively	O
.	O

Percentage	O
of	O
diglycosylated	O
glycoforms	O
plotted	O
as	O
a	O
function	O
of	O
percentage	O
of	O
hypersialylated	O
isoforms	O
for	O
brain	O
-	O
derived	O
(	O
circles	O
)	O
and	O
dsPMCAb	O
-	O
derived	O
materials	O
(	O
diamonds	O
)	O
for	O
mouse	O
(	O
RML	O
,	O
22L	O
and	O
ME7	O
)	O
and	O
hamster	O
(	O
263K	O
,	O
HY	O
,	O
DY	O
and	O
SSLOW	O
)	O
strains	O
.	O

Arrows	O
show	O
shifts	O
in	O
glycoform	O
ratio	O
after	O
amplification	O
in	O
dsPMCAb	O
.	O

Percentage	O
of	O
diglycosylated	O
glycoforms	O
and	O
hypersialylated	O
isoforms	O
are	O
calculated	O
as	O
described	O
in	O
Materials	O
and	O
Methods	O
.	O

For	O
each	O
strain	O
,	O
at	O
least	O
three	O
glycoform	O
ratio	O
values	O
were	O
acquired	O
from	O
independent	O
brain	O
materials	O
or	O
dsPMCA	O
reactions	O
;	O
the	O
variations	O
were	O
used	O
to	O
calculate	O
mean	O
and	O
standard	O
deviations	O
.	O

For	O
RML	O
,	O
22L	O
and	O
263K	O
brain	O
materials	O
at	O
least	O
three	O
sialylation	O
ratio	O
values	O
were	O
available	O
,	O
permitting	O
to	O
calculate	O
mean	O
and	O
standard	O
deviations	O
.	O

Black	O
solid	O
line	O
shows	O
the	O
result	O
of	O
linear	O
fitting	O
of	O
the	O
percent	O
of	O
diglycosylated	O
as	O
a	O
function	O
of	O
the	O
percent	O
of	O
hypersialylated	O
for	O
brain	O
-	O
derived	O
PrPSc	O
,	O
R2	O
=	O
0	O
.	O
89	O
.	O

Sialylation	O
profile	O
of	O
di	O
-	O
(	O
solid	O
lines	O
)	O
or	O
mono	O
-	O
glycosylated	O
(	O
dashed	O
lines	O
)	O
glycofoms	O
of	O
brain	O
-	O
derived	O
materials	O
for	O
263K	O
,	O
22L	O
,	O
ME7	O
and	O
RML	O
.	O

Profiles	O
were	O
built	O
as	O
described	O
in	O
Materials	O
and	O
Methods	O
using	O
results	O
of	O
2D	O
Western	O
blots	O
.	O

Mouse	O
scrapie	O
brain	O
materials	O
were	O
diluted	O
102	O
-	O
fold	O
into	O
10	O
%	O
МоNBH	O
or	O
desialylated	O
МоNBH	O
and	O
subjected	O
to	O
four	O
serial	O
PMCAb	O
or	O
dsPMCAb	O
rounds	O
.	O

The	O
material	O
amplified	O
in	O
each	O
round	O
was	O
diluted	O
to	O
a	O
specified	O
dilution	O
fold	O
for	O
the	O
next	O
round	O
as	O
indicated	O
.	O

Unamplified	O
scrapie	O
seeds	O
diluted	O
into	O
NBH	O
are	O
shown	O
as	O
round	O
0	O
.	O

Samples	O
were	O
treated	O
with	O
PK	O
as	O
indicated	O
.	O

All	O
blots	O
were	O
stained	O
with	O
Аb3531	O
antibody	O
.	O

(	O
A	O
)	O
A	O
strain	O
with	O
minor	O
clashes	O
between	O
glycans	O
that	O
belong	O
to	O
neighboring	O
PrP	O
monomers	O
can	O
recruit	O
diglycosylated	O
monomers	O
.	O

This	O
strain	O
is	O
characterized	O
by	O
low	O
electrostatic	O
repulsion	O
between	O
sialylated	O
glycans	O
(	O
schematically	O
marked	O
by	O
lightning	O
bolts	O
).	O

(	O
B	O
)	O
A	O
strain	O
with	O
substantial	O
spatial	O
constraints	O
between	O
glycans	O
from	O
neighboring	O
monomers	O
limits	O
percentage	O
of	O
diglycosylated	O
molecules	O
due	O
to	O
high	O
electrostatic	O
repulsion	O
between	O
sialic	O
acids	O
(	O
red	O
circles	O
with	O
negative	O
charge	O
)	O
from	O
neighboring	O
N	O
-	O
glycans	O
.	O

